Physician profile
John B Brinkman
NPI 1881668150
$841.01
in general payments reported to CMS, 2019-2025
9 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.61 · 2021: $18.42 · 2022: $16.35 · 2023: $337 · 2024: $176 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $517.32 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $194.91 | 2023-2025 | Axonics, Spyglass |
| Cure Medical LLC | $32.18 | 2019 | |
| Axonics, INC. | $19.40 | 2023 | Bulkamid, Axonics |
| Medtronic, INC. | $18.42 | 2021 | |
| Urovant Sciences INC | $16.35 | 2022 | |
| Pfizer INC. | $15.02 | 2019 | |
| Astellas Pharma US INC | $14.91 | 2019 | |
| Coloplast Corp | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brinkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.